Volumen 3, Asunto 2 (2013)
Prospectiva de senderos clínicos
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Revisión: resultados del ensayo clínico
Daclatasvir, an efficient inhibitor of the hepatitis C virus replication complex protein NS5A: review of virologic data, treatment ationale and clinical trials.
Stanislas Pol
Actualización de la investigación
Helping each other regulate clinical trials: a network of vaccine regulators from developing countries
Sergio A Nishioka, James Southern, Rolando Dominguez, Nora Dellepiane
Revisión: resultados del ensayo clínico
Future perspectives on the pharmacological management of depression
Sarah Yates, Eleanor Smith, Hamid A Alhaj, R Hamish McAllister-Williams
Prospectiva de senderos clínicos
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Revisión: resultados del ensayo clínico
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Revisión: resultados del ensayo clínico
Mesenchymal stem cells in neurological diseases
Ibrahim Kassis, Panayiota Petrou, Adi Vaknin-Dembinsky, Dimitrios Karussis
